Stay updated on Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Fatty Liver Disease was added as a related topic and How to Prevent Diabetes was removed as a related topic.
    Difference
    0.1%
    Check dated 2025-12-09T19:51:51.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Publications section now includes a note that items are automatically filled from PubMed and may not all pertain to the study, and the page revision has been updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:55:47.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Notice about government funding lapse and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:25:47.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Study Details content remains unchanged; there are no additions or deletions to the study information. The new screenshot shows only minor layout adjustments.
    Difference
    0.4%
    Check dated 2025-11-03T21:34:53.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Updated page to v3.2.0 with a new government operating status notice; removed v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T07:54:15.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring and possible narrowing of the domain coverage.
    Difference
    0.5%
    Check dated 2025-09-29T04:25:19.000Z thumbnail image

Stay in the know with updates to Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.